Loading...

The antitumour activity of 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF receptor-1 knockout mice

5,6-dimethylxanthenone-4-acetic acid, a novel antivascular anticancer drug, has completed Phase I clinical trial. Its actions in mice include tumour necrosis factor induction, serotonin release, tumour blood flow inhibition, and the induction of tumour haemorrhagic necrosis and regression. We have u...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Zhao, L, Ching, L-M, Kestell, P, Baguley, B C
Format: Artigo
Sprog:Inglês
Udgivet: Nature Publishing Group 2002
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376130/
https://ncbi.nlm.nih.gov/pubmed/12177785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6600479
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!